Mallinckrodt PLC (NYSE:MNK) – Stock analysts at Jefferies Financial Group lowered their Q3 2019 EPS estimates for shares of Mallinckrodt in a report issued on Wednesday, May 22nd. Jefferies Financial Group analyst A. Petrone now anticipates that the company will post earnings per share of $1.99 for the quarter, down from their previous estimate of $2.12. Jefferies Financial Group has a “Hold” rating and a $15.00 price objective on the stock. Jefferies Financial Group also issued estimates for Mallinckrodt’s FY2019 earnings at $8.35 EPS, FY2020 earnings at $8.55 EPS, FY2021 earnings at $8.70 EPS, FY2022 earnings at $8.94 EPS and FY2023 earnings at $9.74 EPS.

Mallinckrodt (NYSE:MNK) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $1.94 EPS for the quarter, beating the Zacks’ consensus estimate of $1.73 by $0.21. The company had revenue of $791.00 million during the quarter, compared to the consensus estimate of $766.27 million. Mallinckrodt had a positive return on equity of 14.22% and a negative net margin of 118.53%. Mallinckrodt’s revenue was up 4.7% on a year-over-year basis. During the same period last year, the business posted $1.31 earnings per share.

A number of other brokerages also recently commented on MNK. Canaccord Genuity set a $40.00 price target on Mallinckrodt and gave the company a “buy” rating in a research report on Monday, March 18th. Mizuho increased their price target on Mallinckrodt to $26.00 and gave the company a “neutral” rating in a research report on Thursday, February 28th. SunTrust Banks set a $20.00 price target on Mallinckrodt and gave the company a “hold” rating in a research report on Tuesday, May 14th. JPMorgan Chase & Co. decreased their price target on Mallinckrodt from $22.00 to $11.00 and set a “neutral” rating for the company in a research report on Friday. Finally, ValuEngine downgraded Mallinckrodt from a “hold” rating to a “sell” rating in a research report on Tuesday, March 5th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $26.72.

Shares of MNK opened at $9.61 on Friday. The company has a debt-to-equity ratio of 1.90, a current ratio of 1.45 and a quick ratio of 1.08. The company has a market cap of $827.24 million, a P/E ratio of 1.20, a price-to-earnings-growth ratio of 0.10 and a beta of 2.12. Mallinckrodt has a 12 month low of $8.45 and a 12 month high of $36.65.

A number of hedge funds and other institutional investors have recently made changes to their positions in MNK. CWM LLC boosted its holdings in shares of Mallinckrodt by 222.8% in the first quarter. CWM LLC now owns 1,159 shares of the company’s stock worth $25,000 after acquiring an additional 800 shares during the period. Oregon Public Employees Retirement Fund boosted its holdings in shares of Mallinckrodt by 1,480.0% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 520,326 shares of the company’s stock worth $33,000 after acquiring an additional 487,394 shares during the period. FNY Investment Advisers LLC boosted its holdings in shares of Mallinckrodt by 210.4% in the fourth quarter. FNY Investment Advisers LLC now owns 2,288 shares of the company’s stock worth $36,000 after acquiring an additional 1,551 shares during the period. We Are One Seven LLC bought a new position in shares of Mallinckrodt in the fourth quarter worth $38,000. Finally, QS Investors LLC boosted its holdings in shares of Mallinckrodt by 14.3% in the fourth quarter. QS Investors LLC now owns 4,000 shares of the company’s stock worth $64,000 after acquiring an additional 500 shares during the period.

About Mallinckrodt

Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.

Featured Article: Put Option

Earnings History and Estimates for Mallinckrodt (NYSE:MNK)

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.